<DOC>
	<DOCNO>NCT02171208</DOCNO>
	<brief_summary>The primary objective study establish bioequivalence test product ( BG00012 [ dimethyl fumarate ] supply Biogen Idec OSD ) reference product ( BG00012 supply Vifor SA ) comparison pharmacokinetic ( PK ) profile healthy volunteer . The secondary objective study determine safety tolerability test product compare reference product , estimate PK parameter test product reference product , estimate intra-subject coefficient variation ( CV % ) reference product area plasma concentration curve ( AUC ) peak plasma concentration ( Cmax ) .</brief_summary>
	<brief_title>A Healthy Volunteer Study Establish Bioequivalence BG00012 Supplied 2 Different Commercial Manufacturers</brief_title>
	<detailed_description />
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<criteria>Key BMI 19.0 30.0 kg/m2 , inclusive Subjects reproductive potential must agree practice effective contraception least 14 day prior first dose study drug least 30 day last dose study drug . Key History clinically significant cardiac , endocrine , GI , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , major disease , determine Investigator . Treatment another investigational drug approve therapy investigational use within 30 day ( 5 halflives , whichever long ) prior Day 1 . NOTE : Other protocol define Inclusion/Exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>